These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

267 related items for PubMed ID: 31962163

  • 1. Determining Whether Prophylactic Antiviral Treatment Is Necessary in HBsAg-Negative/HBcAb-Positive Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation.
    Zhang A, Wu Y, Tan Y, Shi J, Zhao Y, Hu Y, Yu J, Zheng W, Lai X, Zhang M, Zhu Y, Ye Y, Huang Y, Fu S, Huang H, Luo Y.
    Biol Blood Marrow Transplant; 2020 May; 26(5):956-964. PubMed ID: 31962163
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Changes in hepatitis B virus surface antibody titer and risk of hepatitis B reactivation in HBsAg-negative/HBcAb-positive patients undergoing biologic therapy for rheumatic diseases: a prospective cohort study.
    Tien YC, Yen HH, Li CF, Liu MP, Hsue YT, Hung MH, Chiu YM.
    Arthritis Res Ther; 2018 Nov 01; 20(1):246. PubMed ID: 30382902
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Late HBsAg seroreversion of mutated hepatitis B virus after bone marrow transplantation.
    Schubert A, Michel D, Mertens T.
    BMC Infect Dis; 2013 May 16; 13():223. PubMed ID: 23679074
    [Abstract] [Full Text] [Related]

  • 6. Management of Hepatitis B Virus in Allogeneic Hematopoietic Stem Cell Transplantation.
    Wu Y, Huang H, Luo Y.
    Front Immunol; 2020 May 16; 11():610500. PubMed ID: 33613534
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Kinetics of viral loads and risk of hepatitis B virus reactivation in hepatitis B core antibody-positive rheumatoid arthritis patients undergoing anti-tumour necrosis factor alpha therapy.
    Lan JL, Chen YM, Hsieh TY, Chen YH, Hsieh CW, Chen DY, Yang SS.
    Ann Rheum Dis; 2011 Oct 16; 70(10):1719-25. PubMed ID: 21719446
    [Abstract] [Full Text] [Related]

  • 9. Reactivation of hepatitis B virus infection following rituximab treatment in HBsAg-negative, HBcAb-positive rheumatoid arthritis patients: A long-term, real-world observation.
    Chen YM, Chen HH, Huang WN, Chen YH, Hsieh TY, Yang SS, Lan JL, Chen DY.
    Int J Rheum Dis; 2019 Jun 16; 22(6):1145-1151. PubMed ID: 31117160
    [Abstract] [Full Text] [Related]

  • 10. Hepatitis B reactivation in HBsAg-negative/HBcAb-positive patients receiving immunosuppressive therapy for glomerulonephritis: a retrospective analysis.
    Fang J, Li W, Peng X, Tan Z, Tan M, Zhang C, Wang W, Xu Z, Zhou G.
    Int Urol Nephrol; 2017 Mar 16; 49(3):475-482. PubMed ID: 28032257
    [Abstract] [Full Text] [Related]

  • 11. Clinical and virological factors associated with hepatitis B virus reactivation in HBsAg-negative and anti-HBc antibodies-positive patients undergoing chemotherapy and/or autologous stem cell transplantation for cancer.
    Borentain P, Colson P, Coso D, Bories E, Charbonnier A, Stoppa AM, Auran T, Loundou A, Motte A, Ressiot E, Norguet E, Chabannon C, Bouabdallah R, Tamalet C, Gérolami R.
    J Viral Hepat; 2010 Nov 16; 17(11):807-15. PubMed ID: 20002298
    [Abstract] [Full Text] [Related]

  • 12. [The influence of hepatitis B virus infection on patients undergoing allogeneic hematopoietic stem cell transplantation].
    Liang C, Jiang EL, Huang Y, Yan ZS, Yang DL, He Y, Ma QL, Wei JL, Wang M, Feng SZ, Qiu LG, Han MZ.
    Zhonghua Xue Ye Xue Za Zhi; 2010 Jul 16; 31(7):456-60. PubMed ID: 21122399
    [Abstract] [Full Text] [Related]

  • 13. Low incidence of hepatitis B virus reactivation during chemotherapy among diffuse large B-cell lymphoma patients who are HBsAg-negative/ HBcAb-positive: a multicenter retrospective study.
    Ji D, Cao J, Hong X, Li J, Wang J, Chen F, Wang C, Zou S.
    Eur J Haematol; 2010 Sep 16; 85(3):243-50. PubMed ID: 20491883
    [Abstract] [Full Text] [Related]

  • 14. Hepatitis B reactivation in HBsAg-negative/HBcAb-positive allogeneic haematopoietic stem cell transplant recipients: risk factors and outcome.
    Mikulska M, Nicolini L, Signori A, Rivoli G, Del Bono V, Raiola AM, Di Grazia C, Dominietto A, Varaldo R, Ghiso A, Bacigalupo A, Viscoli C.
    Clin Microbiol Infect; 2014 Oct 16; 20(10):O694-701. PubMed ID: 24575948
    [Abstract] [Full Text] [Related]

  • 15. Prophylactic antiviral therapy in allogeneic hematopoietic stem cell transplantation in hepatitis B virus patients.
    Liao YP, Jiang JL, Zou WY, Xu DR, Li J.
    World J Gastroenterol; 2015 Apr 14; 21(14):4284-92. PubMed ID: 25892880
    [Abstract] [Full Text] [Related]

  • 16. Kidney Transplantation From Hepatitis B Surface Antigen (HBsAg)-Positive Living Donors to HBsAg-Negative Recipients: Clinical Outcomes at a High-Volume Center in China.
    Wang XD, Liu JP, Song TR, Huang ZL, Fan Y, Shi YY, Chen LY, Lv YH, Xu ZL, Li XH, Wang L, Lin T.
    Clin Infect Dis; 2021 Mar 15; 72(6):1016-1023. PubMed ID: 32100025
    [Abstract] [Full Text] [Related]

  • 17. Hepatitis B immunization status and risk factors of people aged 1 to 69 in Huangpu District, Shanghai, China.
    Wang Y, Shu M, Chen J, Shen F, Ren H, Yu Y.
    Front Public Health; 2023 Mar 15; 11():1302183. PubMed ID: 38179572
    [Abstract] [Full Text] [Related]

  • 18. Effectiveness of prophylactic antiviral therapy in reducing HBV reactivation for HBsAg-positive recipients following allogeneic hematopoietic stem cell transplantation: a multi-institutional experience from an HBV endemic area.
    Wu Y, Chen Y, Zhu P, Ye B, Lu Y, Shi J, Tan Y, Zhao Y, Yu J, Lai X, Lan J, Si T, Ni L, Huang H, Luo Y.
    Ann Hematol; 2022 Mar 15; 101(3):631-641. PubMed ID: 34981143
    [Abstract] [Full Text] [Related]

  • 19. Impact of Hepatitis B Core Antibody Seropositivity on the Outcome of Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma.
    Varma A, Biritxinaga L, Saliba RM, Stich M, Jauch SF, Afrough A, Honhar M, Popat UR, Shafi MA, Shah N, Bashir Q, Dinh Y, Hosing C, Champlin RE, Qazilbash MH.
    Biol Blood Marrow Transplant; 2017 Apr 15; 23(4):581-587. PubMed ID: 28063964
    [Abstract] [Full Text] [Related]

  • 20. Hepatitis B Seropositive Status in Recipients or Donors Is Not Related to Worse Outcomes after Haploidentical Hematopoietic Stem Cell Transplantation.
    Yu C, Sun Y, Xu L, Zhang X, Liu K, Jin J, Huang X, Wang Y.
    Transplant Cell Ther; 2021 Aug 15; 27(8):668.e1-668.e9. PubMed ID: 34052506
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.